Pharma & Healthcare
Global Famciclovir Market Research Report 2024
- Jan 18, 24
- ID: 3182
- Pages: 93
- Figures: 202
- Views: 31
Famciclovir is an antiviral drug. It slows the growth and spread of the herpes virus so that the body can fight off the infection. Famciclovir will not cure herpes, but it can lessen the symptoms of the infections.
The global Famciclovir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Famciclovir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Famciclovir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Famciclovir include Novartis, Mylan, Teva, Cipla, Hikma, Apotex, Aurobindo Pharma, Macleods Pharmaceuticals and Beijing Jialin Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Famciclovir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Famciclovir.
Report Scope
The Famciclovir market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Famciclovir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Famciclovir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Mylan
Teva
Cipla
Hikma
Apotex
Aurobindo Pharma
Macleods Pharmaceuticals
Beijing Jialin Pharmaceutical
HETERO
Hainan choitec Pharmaceuticals
Shandong Luoxin Pharmaceutical Group
Chengdu Diao Pharmaceutical Group
HISUN
Segment by Type
125 mg Tablets
250 mg Tablets
500 mg Tablets
Segment by Application
Cold Sores
Genital Herpes
Shingles
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Famciclovir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Famciclovir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Famciclovir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Famciclovir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Famciclovir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Famciclovir include Novartis, Mylan, Teva, Cipla, Hikma, Apotex, Aurobindo Pharma, Macleods Pharmaceuticals and Beijing Jialin Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Famciclovir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Famciclovir.
Report Scope
The Famciclovir market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Famciclovir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Famciclovir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Mylan
Teva
Cipla
Hikma
Apotex
Aurobindo Pharma
Macleods Pharmaceuticals
Beijing Jialin Pharmaceutical
HETERO
Hainan choitec Pharmaceuticals
Shandong Luoxin Pharmaceutical Group
Chengdu Diao Pharmaceutical Group
HISUN
Segment by Type
125 mg Tablets
250 mg Tablets
500 mg Tablets
Segment by Application
Cold Sores
Genital Herpes
Shingles
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Famciclovir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Famciclovir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Famciclovir Market Overview
1.1 Product Overview and Scope of Famciclovir
1.2 Famciclovir Segment by Type
1.2.1 Global Famciclovir Market Value Comparison by Type (2024-2030)
1.2.2 125 mg Tablets
1.2.3 250 mg Tablets
1.2.4 500 mg Tablets
1.3 Famciclovir Segment by Application
1.3.1 Global Famciclovir Market Value by Application: (2024-2030)
1.3.2 Cold Sores
1.3.3 Genital Herpes
1.3.4 Shingles
1.4 Global Famciclovir Market Size Estimates and Forecasts
1.4.1 Global Famciclovir Revenue 2019-2030
1.4.2 Global Famciclovir Sales 2019-2030
1.4.3 Global Famciclovir Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Famciclovir Market Competition by Manufacturers
2.1 Global Famciclovir Sales Market Share by Manufacturers (2019-2024)
2.2 Global Famciclovir Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Famciclovir Average Price by Manufacturers (2019-2024)
2.4 Global Famciclovir Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Famciclovir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Famciclovir, Product Type & Application
2.7 Famciclovir Market Competitive Situation and Trends
2.7.1 Famciclovir Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Famciclovir Players Market Share by Revenue
2.7.3 Global Famciclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Famciclovir Retrospective Market Scenario by Region
3.1 Global Famciclovir Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Famciclovir Global Famciclovir Sales by Region: 2019-2030
3.2.1 Global Famciclovir Sales by Region: 2019-2024
3.2.2 Global Famciclovir Sales by Region: 2025-2030
3.3 Global Famciclovir Global Famciclovir Revenue by Region: 2019-2030
3.3.1 Global Famciclovir Revenue by Region: 2019-2024
3.3.2 Global Famciclovir Revenue by Region: 2025-2030
3.4 North America Famciclovir Market Facts & Figures by Country
3.4.1 North America Famciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Famciclovir Sales by Country (2019-2030)
3.4.3 North America Famciclovir Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Famciclovir Market Facts & Figures by Country
3.5.1 Europe Famciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Famciclovir Sales by Country (2019-2030)
3.5.3 Europe Famciclovir Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Famciclovir Market Facts & Figures by Country
3.6.1 Asia Pacific Famciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Famciclovir Sales by Country (2019-2030)
3.6.3 Asia Pacific Famciclovir Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Famciclovir Market Facts & Figures by Country
3.7.1 Latin America Famciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Famciclovir Sales by Country (2019-2030)
3.7.3 Latin America Famciclovir Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Famciclovir Market Facts & Figures by Country
3.8.1 Middle East and Africa Famciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Famciclovir Sales by Country (2019-2030)
3.8.3 Middle East and Africa Famciclovir Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Famciclovir Sales by Type (2019-2030)
4.1.1 Global Famciclovir Sales by Type (2019-2024)
4.1.2 Global Famciclovir Sales by Type (2025-2030)
4.1.3 Global Famciclovir Sales Market Share by Type (2019-2030)
4.2 Global Famciclovir Revenue by Type (2019-2030)
4.2.1 Global Famciclovir Revenue by Type (2019-2024)
4.2.2 Global Famciclovir Revenue by Type (2025-2030)
4.2.3 Global Famciclovir Revenue Market Share by Type (2019-2030)
4.3 Global Famciclovir Price by Type (2019-2030)
5 Segment by Application
5.1 Global Famciclovir Sales by Application (2019-2030)
5.1.1 Global Famciclovir Sales by Application (2019-2024)
5.1.2 Global Famciclovir Sales by Application (2025-2030)
5.1.3 Global Famciclovir Sales Market Share by Application (2019-2030)
5.2 Global Famciclovir Revenue by Application (2019-2030)
5.2.1 Global Famciclovir Revenue by Application (2019-2024)
5.2.2 Global Famciclovir Revenue by Application (2025-2030)
5.2.3 Global Famciclovir Revenue Market Share by Application (2019-2030)
5.3 Global Famciclovir Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Famciclovir Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan Famciclovir Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Famciclovir Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Corporation Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cipla Famciclovir Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Hikma
6.5.1 Hikma Corporation Information
6.5.2 Hikma Description and Business Overview
6.5.3 Hikma Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hikma Famciclovir Product Portfolio
6.5.5 Hikma Recent Developments/Updates
6.6 Apotex
6.6.1 Apotex Corporation Information
6.6.2 Apotex Description and Business Overview
6.6.3 Apotex Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Apotex Famciclovir Product Portfolio
6.6.5 Apotex Recent Developments/Updates
6.7 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aurobindo Pharma Famciclovir Product Portfolio
6.7.5 Aurobindo Pharma Recent Developments/Updates
6.8 Macleods Pharmaceuticals
6.8.1 Macleods Pharmaceuticals Corporation Information
6.8.2 Macleods Pharmaceuticals Description and Business Overview
6.8.3 Macleods Pharmaceuticals Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Macleods Pharmaceuticals Famciclovir Product Portfolio
6.8.5 Macleods Pharmaceuticals Recent Developments/Updates
6.9 Beijing Jialin Pharmaceutical
6.9.1 Beijing Jialin Pharmaceutical Corporation Information
6.9.2 Beijing Jialin Pharmaceutical Description and Business Overview
6.9.3 Beijing Jialin Pharmaceutical Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Beijing Jialin Pharmaceutical Famciclovir Product Portfolio
6.9.5 Beijing Jialin Pharmaceutical Recent Developments/Updates
6.10 HETERO
6.10.1 HETERO Corporation Information
6.10.2 HETERO Description and Business Overview
6.10.3 HETERO Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.10.4 HETERO Famciclovir Product Portfolio
6.10.5 HETERO Recent Developments/Updates
6.11 Hainan choitec Pharmaceuticals
6.11.1 Hainan choitec Pharmaceuticals Corporation Information
6.11.2 Hainan choitec Pharmaceuticals Famciclovir Description and Business Overview
6.11.3 Hainan choitec Pharmaceuticals Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hainan choitec Pharmaceuticals Famciclovir Product Portfolio
6.11.5 Hainan choitec Pharmaceuticals Recent Developments/Updates
6.12 Shandong Luoxin Pharmaceutical Group
6.12.1 Shandong Luoxin Pharmaceutical Group Corporation Information
6.12.2 Shandong Luoxin Pharmaceutical Group Famciclovir Description and Business Overview
6.12.3 Shandong Luoxin Pharmaceutical Group Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolio
6.12.5 Shandong Luoxin Pharmaceutical Group Recent Developments/Updates
6.13 Chengdu Diao Pharmaceutical Group
6.13.1 Chengdu Diao Pharmaceutical Group Corporation Information
6.13.2 Chengdu Diao Pharmaceutical Group Famciclovir Description and Business Overview
6.13.3 Chengdu Diao Pharmaceutical Group Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolio
6.13.5 Chengdu Diao Pharmaceutical Group Recent Developments/Updates
6.14 HISUN
6.14.1 HISUN Corporation Information
6.14.2 HISUN Famciclovir Description and Business Overview
6.14.3 HISUN Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.14.4 HISUN Famciclovir Product Portfolio
6.14.5 HISUN Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Famciclovir Industry Chain Analysis
7.2 Famciclovir Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Famciclovir Production Mode & Process
7.4 Famciclovir Sales and Marketing
7.4.1 Famciclovir Sales Channels
7.4.2 Famciclovir Distributors
7.5 Famciclovir Customers
8 Famciclovir Market Dynamics
8.1 Famciclovir Industry Trends
8.2 Famciclovir Market Drivers
8.3 Famciclovir Market Challenges
8.4 Famciclovir Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Famciclovir
1.2 Famciclovir Segment by Type
1.2.1 Global Famciclovir Market Value Comparison by Type (2024-2030)
1.2.2 125 mg Tablets
1.2.3 250 mg Tablets
1.2.4 500 mg Tablets
1.3 Famciclovir Segment by Application
1.3.1 Global Famciclovir Market Value by Application: (2024-2030)
1.3.2 Cold Sores
1.3.3 Genital Herpes
1.3.4 Shingles
1.4 Global Famciclovir Market Size Estimates and Forecasts
1.4.1 Global Famciclovir Revenue 2019-2030
1.4.2 Global Famciclovir Sales 2019-2030
1.4.3 Global Famciclovir Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Famciclovir Market Competition by Manufacturers
2.1 Global Famciclovir Sales Market Share by Manufacturers (2019-2024)
2.2 Global Famciclovir Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Famciclovir Average Price by Manufacturers (2019-2024)
2.4 Global Famciclovir Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Famciclovir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Famciclovir, Product Type & Application
2.7 Famciclovir Market Competitive Situation and Trends
2.7.1 Famciclovir Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Famciclovir Players Market Share by Revenue
2.7.3 Global Famciclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Famciclovir Retrospective Market Scenario by Region
3.1 Global Famciclovir Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Famciclovir Global Famciclovir Sales by Region: 2019-2030
3.2.1 Global Famciclovir Sales by Region: 2019-2024
3.2.2 Global Famciclovir Sales by Region: 2025-2030
3.3 Global Famciclovir Global Famciclovir Revenue by Region: 2019-2030
3.3.1 Global Famciclovir Revenue by Region: 2019-2024
3.3.2 Global Famciclovir Revenue by Region: 2025-2030
3.4 North America Famciclovir Market Facts & Figures by Country
3.4.1 North America Famciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Famciclovir Sales by Country (2019-2030)
3.4.3 North America Famciclovir Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Famciclovir Market Facts & Figures by Country
3.5.1 Europe Famciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Famciclovir Sales by Country (2019-2030)
3.5.3 Europe Famciclovir Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Famciclovir Market Facts & Figures by Country
3.6.1 Asia Pacific Famciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Famciclovir Sales by Country (2019-2030)
3.6.3 Asia Pacific Famciclovir Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Famciclovir Market Facts & Figures by Country
3.7.1 Latin America Famciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Famciclovir Sales by Country (2019-2030)
3.7.3 Latin America Famciclovir Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Famciclovir Market Facts & Figures by Country
3.8.1 Middle East and Africa Famciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Famciclovir Sales by Country (2019-2030)
3.8.3 Middle East and Africa Famciclovir Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Famciclovir Sales by Type (2019-2030)
4.1.1 Global Famciclovir Sales by Type (2019-2024)
4.1.2 Global Famciclovir Sales by Type (2025-2030)
4.1.3 Global Famciclovir Sales Market Share by Type (2019-2030)
4.2 Global Famciclovir Revenue by Type (2019-2030)
4.2.1 Global Famciclovir Revenue by Type (2019-2024)
4.2.2 Global Famciclovir Revenue by Type (2025-2030)
4.2.3 Global Famciclovir Revenue Market Share by Type (2019-2030)
4.3 Global Famciclovir Price by Type (2019-2030)
5 Segment by Application
5.1 Global Famciclovir Sales by Application (2019-2030)
5.1.1 Global Famciclovir Sales by Application (2019-2024)
5.1.2 Global Famciclovir Sales by Application (2025-2030)
5.1.3 Global Famciclovir Sales Market Share by Application (2019-2030)
5.2 Global Famciclovir Revenue by Application (2019-2030)
5.2.1 Global Famciclovir Revenue by Application (2019-2024)
5.2.2 Global Famciclovir Revenue by Application (2025-2030)
5.2.3 Global Famciclovir Revenue Market Share by Application (2019-2030)
5.3 Global Famciclovir Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Famciclovir Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan Famciclovir Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Famciclovir Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Corporation Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cipla Famciclovir Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Hikma
6.5.1 Hikma Corporation Information
6.5.2 Hikma Description and Business Overview
6.5.3 Hikma Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hikma Famciclovir Product Portfolio
6.5.5 Hikma Recent Developments/Updates
6.6 Apotex
6.6.1 Apotex Corporation Information
6.6.2 Apotex Description and Business Overview
6.6.3 Apotex Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Apotex Famciclovir Product Portfolio
6.6.5 Apotex Recent Developments/Updates
6.7 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aurobindo Pharma Famciclovir Product Portfolio
6.7.5 Aurobindo Pharma Recent Developments/Updates
6.8 Macleods Pharmaceuticals
6.8.1 Macleods Pharmaceuticals Corporation Information
6.8.2 Macleods Pharmaceuticals Description and Business Overview
6.8.3 Macleods Pharmaceuticals Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Macleods Pharmaceuticals Famciclovir Product Portfolio
6.8.5 Macleods Pharmaceuticals Recent Developments/Updates
6.9 Beijing Jialin Pharmaceutical
6.9.1 Beijing Jialin Pharmaceutical Corporation Information
6.9.2 Beijing Jialin Pharmaceutical Description and Business Overview
6.9.3 Beijing Jialin Pharmaceutical Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Beijing Jialin Pharmaceutical Famciclovir Product Portfolio
6.9.5 Beijing Jialin Pharmaceutical Recent Developments/Updates
6.10 HETERO
6.10.1 HETERO Corporation Information
6.10.2 HETERO Description and Business Overview
6.10.3 HETERO Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.10.4 HETERO Famciclovir Product Portfolio
6.10.5 HETERO Recent Developments/Updates
6.11 Hainan choitec Pharmaceuticals
6.11.1 Hainan choitec Pharmaceuticals Corporation Information
6.11.2 Hainan choitec Pharmaceuticals Famciclovir Description and Business Overview
6.11.3 Hainan choitec Pharmaceuticals Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hainan choitec Pharmaceuticals Famciclovir Product Portfolio
6.11.5 Hainan choitec Pharmaceuticals Recent Developments/Updates
6.12 Shandong Luoxin Pharmaceutical Group
6.12.1 Shandong Luoxin Pharmaceutical Group Corporation Information
6.12.2 Shandong Luoxin Pharmaceutical Group Famciclovir Description and Business Overview
6.12.3 Shandong Luoxin Pharmaceutical Group Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolio
6.12.5 Shandong Luoxin Pharmaceutical Group Recent Developments/Updates
6.13 Chengdu Diao Pharmaceutical Group
6.13.1 Chengdu Diao Pharmaceutical Group Corporation Information
6.13.2 Chengdu Diao Pharmaceutical Group Famciclovir Description and Business Overview
6.13.3 Chengdu Diao Pharmaceutical Group Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolio
6.13.5 Chengdu Diao Pharmaceutical Group Recent Developments/Updates
6.14 HISUN
6.14.1 HISUN Corporation Information
6.14.2 HISUN Famciclovir Description and Business Overview
6.14.3 HISUN Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.14.4 HISUN Famciclovir Product Portfolio
6.14.5 HISUN Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Famciclovir Industry Chain Analysis
7.2 Famciclovir Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Famciclovir Production Mode & Process
7.4 Famciclovir Sales and Marketing
7.4.1 Famciclovir Sales Channels
7.4.2 Famciclovir Distributors
7.5 Famciclovir Customers
8 Famciclovir Market Dynamics
8.1 Famciclovir Industry Trends
8.2 Famciclovir Market Drivers
8.3 Famciclovir Market Challenges
8.4 Famciclovir Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Famciclovir Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Famciclovir Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Famciclovir Market Competitive Situation by Manufacturers in 2023
Table 4. Global Famciclovir Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Famciclovir Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Famciclovir Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Famciclovir Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Famciclovir Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Famciclovir, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Famciclovir, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Famciclovir, Product Type & Application
Table 12. Global Key Manufacturers of Famciclovir, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Famciclovir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Famciclovir as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Famciclovir Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Famciclovir Sales by Region (2019-2024) & (K Units)
Table 18. Global Famciclovir Sales Market Share by Region (2019-2024)
Table 19. Global Famciclovir Sales by Region (2025-2030) & (K Units)
Table 20. Global Famciclovir Sales Market Share by Region (2025-2030)
Table 21. Global Famciclovir Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Famciclovir Revenue Market Share by Region (2019-2024)
Table 23. Global Famciclovir Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Famciclovir Revenue Market Share by Region (2025-2030)
Table 25. North America Famciclovir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Famciclovir Sales by Country (2019-2024) & (K Units)
Table 27. North America Famciclovir Sales by Country (2025-2030) & (K Units)
Table 28. North America Famciclovir Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Famciclovir Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Famciclovir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Famciclovir Sales by Country (2019-2024) & (K Units)
Table 32. Europe Famciclovir Sales by Country (2025-2030) & (K Units)
Table 33. Europe Famciclovir Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Famciclovir Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Famciclovir Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Famciclovir Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Famciclovir Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Famciclovir Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Famciclovir Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Famciclovir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Famciclovir Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Famciclovir Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Famciclovir Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Famciclovir Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Famciclovir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Famciclovir Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Famciclovir Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Famciclovir Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Famciclovir Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Famciclovir Sales (K Units) by Type (2019-2024)
Table 51. Global Famciclovir Sales (K Units) by Type (2025-2030)
Table 52. Global Famciclovir Sales Market Share by Type (2019-2024)
Table 53. Global Famciclovir Sales Market Share by Type (2025-2030)
Table 54. Global Famciclovir Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Famciclovir Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Famciclovir Revenue Market Share by Type (2019-2024)
Table 57. Global Famciclovir Revenue Market Share by Type (2025-2030)
Table 58. Global Famciclovir Price (USD/Unit) by Type (2019-2024)
Table 59. Global Famciclovir Price (USD/Unit) by Type (2025-2030)
Table 60. Global Famciclovir Sales (K Units) by Application (2019-2024)
Table 61. Global Famciclovir Sales (K Units) by Application (2025-2030)
Table 62. Global Famciclovir Sales Market Share by Application (2019-2024)
Table 63. Global Famciclovir Sales Market Share by Application (2025-2030)
Table 64. Global Famciclovir Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Famciclovir Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Famciclovir Revenue Market Share by Application (2019-2024)
Table 67. Global Famciclovir Revenue Market Share by Application (2025-2030)
Table 68. Global Famciclovir Price (USD/Unit) by Application (2019-2024)
Table 69. Global Famciclovir Price (USD/Unit) by Application (2025-2030)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Novartis Famciclovir Product
Table 74. Novartis Recent Developments/Updates
Table 75. Mylan Corporation Information
Table 76. Mylan Description and Business Overview
Table 77. Mylan Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Mylan Famciclovir Product
Table 79. Mylan Recent Developments/Updates
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Teva Famciclovir Product
Table 84. Teva Recent Developments/Updates
Table 85. Cipla Corporation Information
Table 86. Cipla Description and Business Overview
Table 87. Cipla Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Cipla Famciclovir Product
Table 89. Cipla Recent Developments/Updates
Table 90. Hikma Corporation Information
Table 91. Hikma Description and Business Overview
Table 92. Hikma Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Hikma Famciclovir Product
Table 94. Hikma Recent Developments/Updates
Table 95. Apotex Corporation Information
Table 96. Apotex Description and Business Overview
Table 97. Apotex Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Apotex Famciclovir Product
Table 99. Apotex Recent Developments/Updates
Table 100. Aurobindo Pharma Corporation Information
Table 101. Aurobindo Pharma Description and Business Overview
Table 102. Aurobindo Pharma Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Aurobindo Pharma Famciclovir Product
Table 104. Aurobindo Pharma Recent Developments/Updates
Table 105. Macleods Pharmaceuticals Corporation Information
Table 106. Macleods Pharmaceuticals Description and Business Overview
Table 107. Macleods Pharmaceuticals Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Macleods Pharmaceuticals Famciclovir Product
Table 109. Macleods Pharmaceuticals Recent Developments/Updates
Table 110. Beijing Jialin Pharmaceutical Corporation Information
Table 111. Beijing Jialin Pharmaceutical Description and Business Overview
Table 112. Beijing Jialin Pharmaceutical Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Beijing Jialin Pharmaceutical Famciclovir Product
Table 114. Beijing Jialin Pharmaceutical Recent Developments/Updates
Table 115. HETERO Corporation Information
Table 116. HETERO Description and Business Overview
Table 117. HETERO Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. HETERO Famciclovir Product
Table 119. HETERO Recent Developments/Updates
Table 120. Hainan choitec Pharmaceuticals Corporation Information
Table 121. Hainan choitec Pharmaceuticals Description and Business Overview
Table 122. Hainan choitec Pharmaceuticals Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Hainan choitec Pharmaceuticals Famciclovir Product
Table 124. Hainan choitec Pharmaceuticals Recent Developments/Updates
Table 125. Shandong Luoxin Pharmaceutical Group Corporation Information
Table 126. Shandong Luoxin Pharmaceutical Group Description and Business Overview
Table 127. Shandong Luoxin Pharmaceutical Group Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Shandong Luoxin Pharmaceutical Group Famciclovir Product
Table 129. Shandong Luoxin Pharmaceutical Group Recent Developments/Updates
Table 130. Chengdu Diao Pharmaceutical Group Corporation Information
Table 131. Chengdu Diao Pharmaceutical Group Description and Business Overview
Table 132. Chengdu Diao Pharmaceutical Group Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Chengdu Diao Pharmaceutical Group Famciclovir Product
Table 134. Chengdu Diao Pharmaceutical Group Recent Developments/Updates
Table 135. HISUN Corporation Information
Table 136. HISUN Description and Business Overview
Table 137. HISUN Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. HISUN Famciclovir Product
Table 139. HISUN Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Famciclovir Distributors List
Table 143. Famciclovir Customers List
Table 144. Famciclovir Market Trends
Table 145. Famciclovir Market Drivers
Table 146. Famciclovir Market Challenges
Table 147. Famciclovir Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Famciclovir
Figure 2. Global Famciclovir Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Famciclovir Market Share by Type in 2023 & 2030
Figure 4. 125 mg Tablets Product Picture
Figure 5. 250 mg Tablets Product Picture
Figure 6. 500 mg Tablets Product Picture
Figure 7. Global Famciclovir Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Famciclovir Market Share by Application in 2023 & 2030
Figure 9. Cold Sores
Figure 10. Genital Herpes
Figure 11. Shingles
Figure 12. Global Famciclovir Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Famciclovir Market Size (2019-2030) & (US$ Million)
Figure 14. Global Famciclovir Sales (2019-2030) & (K Units)
Figure 15. Global Famciclovir Average Price (USD/Unit) & (2019-2030)
Figure 16. Famciclovir Report Years Considered
Figure 17. Famciclovir Sales Share by Manufacturers in 2023
Figure 18. Global Famciclovir Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Famciclovir Players: Market Share by Revenue in 2023
Figure 20. Famciclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Famciclovir Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Famciclovir Sales Market Share by Country (2019-2030)
Figure 23. North America Famciclovir Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Famciclovir Sales Market Share by Country (2019-2030)
Figure 27. Europe Famciclovir Revenue Market Share by Country (2019-2030)
Figure 28. Germany Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Famciclovir Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Famciclovir Revenue Market Share by Region (2019-2030)
Figure 35. China Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Famciclovir Sales Market Share by Country (2019-2030)
Figure 46. Latin America Famciclovir Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Famciclovir Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Famciclovir Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Famciclovir by Type (2019-2030)
Figure 56. Global Revenue Market Share of Famciclovir by Type (2019-2030)
Figure 57. Global Famciclovir Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Famciclovir by Application (2019-2030)
Figure 59. Global Revenue Market Share of Famciclovir by Application (2019-2030)
Figure 60. Global Famciclovir Price (USD/Unit) by Application (2019-2030)
Figure 61. Famciclovir Value Chain
Figure 62. Famciclovir Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Famciclovir Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Famciclovir Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Famciclovir Market Competitive Situation by Manufacturers in 2023
Table 4. Global Famciclovir Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Famciclovir Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Famciclovir Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Famciclovir Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Famciclovir Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Famciclovir, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Famciclovir, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Famciclovir, Product Type & Application
Table 12. Global Key Manufacturers of Famciclovir, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Famciclovir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Famciclovir as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Famciclovir Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Famciclovir Sales by Region (2019-2024) & (K Units)
Table 18. Global Famciclovir Sales Market Share by Region (2019-2024)
Table 19. Global Famciclovir Sales by Region (2025-2030) & (K Units)
Table 20. Global Famciclovir Sales Market Share by Region (2025-2030)
Table 21. Global Famciclovir Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Famciclovir Revenue Market Share by Region (2019-2024)
Table 23. Global Famciclovir Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Famciclovir Revenue Market Share by Region (2025-2030)
Table 25. North America Famciclovir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Famciclovir Sales by Country (2019-2024) & (K Units)
Table 27. North America Famciclovir Sales by Country (2025-2030) & (K Units)
Table 28. North America Famciclovir Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Famciclovir Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Famciclovir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Famciclovir Sales by Country (2019-2024) & (K Units)
Table 32. Europe Famciclovir Sales by Country (2025-2030) & (K Units)
Table 33. Europe Famciclovir Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Famciclovir Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Famciclovir Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Famciclovir Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Famciclovir Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Famciclovir Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Famciclovir Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Famciclovir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Famciclovir Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Famciclovir Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Famciclovir Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Famciclovir Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Famciclovir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Famciclovir Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Famciclovir Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Famciclovir Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Famciclovir Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Famciclovir Sales (K Units) by Type (2019-2024)
Table 51. Global Famciclovir Sales (K Units) by Type (2025-2030)
Table 52. Global Famciclovir Sales Market Share by Type (2019-2024)
Table 53. Global Famciclovir Sales Market Share by Type (2025-2030)
Table 54. Global Famciclovir Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Famciclovir Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Famciclovir Revenue Market Share by Type (2019-2024)
Table 57. Global Famciclovir Revenue Market Share by Type (2025-2030)
Table 58. Global Famciclovir Price (USD/Unit) by Type (2019-2024)
Table 59. Global Famciclovir Price (USD/Unit) by Type (2025-2030)
Table 60. Global Famciclovir Sales (K Units) by Application (2019-2024)
Table 61. Global Famciclovir Sales (K Units) by Application (2025-2030)
Table 62. Global Famciclovir Sales Market Share by Application (2019-2024)
Table 63. Global Famciclovir Sales Market Share by Application (2025-2030)
Table 64. Global Famciclovir Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Famciclovir Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Famciclovir Revenue Market Share by Application (2019-2024)
Table 67. Global Famciclovir Revenue Market Share by Application (2025-2030)
Table 68. Global Famciclovir Price (USD/Unit) by Application (2019-2024)
Table 69. Global Famciclovir Price (USD/Unit) by Application (2025-2030)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Novartis Famciclovir Product
Table 74. Novartis Recent Developments/Updates
Table 75. Mylan Corporation Information
Table 76. Mylan Description and Business Overview
Table 77. Mylan Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Mylan Famciclovir Product
Table 79. Mylan Recent Developments/Updates
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Teva Famciclovir Product
Table 84. Teva Recent Developments/Updates
Table 85. Cipla Corporation Information
Table 86. Cipla Description and Business Overview
Table 87. Cipla Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Cipla Famciclovir Product
Table 89. Cipla Recent Developments/Updates
Table 90. Hikma Corporation Information
Table 91. Hikma Description and Business Overview
Table 92. Hikma Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Hikma Famciclovir Product
Table 94. Hikma Recent Developments/Updates
Table 95. Apotex Corporation Information
Table 96. Apotex Description and Business Overview
Table 97. Apotex Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Apotex Famciclovir Product
Table 99. Apotex Recent Developments/Updates
Table 100. Aurobindo Pharma Corporation Information
Table 101. Aurobindo Pharma Description and Business Overview
Table 102. Aurobindo Pharma Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Aurobindo Pharma Famciclovir Product
Table 104. Aurobindo Pharma Recent Developments/Updates
Table 105. Macleods Pharmaceuticals Corporation Information
Table 106. Macleods Pharmaceuticals Description and Business Overview
Table 107. Macleods Pharmaceuticals Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Macleods Pharmaceuticals Famciclovir Product
Table 109. Macleods Pharmaceuticals Recent Developments/Updates
Table 110. Beijing Jialin Pharmaceutical Corporation Information
Table 111. Beijing Jialin Pharmaceutical Description and Business Overview
Table 112. Beijing Jialin Pharmaceutical Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Beijing Jialin Pharmaceutical Famciclovir Product
Table 114. Beijing Jialin Pharmaceutical Recent Developments/Updates
Table 115. HETERO Corporation Information
Table 116. HETERO Description and Business Overview
Table 117. HETERO Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. HETERO Famciclovir Product
Table 119. HETERO Recent Developments/Updates
Table 120. Hainan choitec Pharmaceuticals Corporation Information
Table 121. Hainan choitec Pharmaceuticals Description and Business Overview
Table 122. Hainan choitec Pharmaceuticals Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Hainan choitec Pharmaceuticals Famciclovir Product
Table 124. Hainan choitec Pharmaceuticals Recent Developments/Updates
Table 125. Shandong Luoxin Pharmaceutical Group Corporation Information
Table 126. Shandong Luoxin Pharmaceutical Group Description and Business Overview
Table 127. Shandong Luoxin Pharmaceutical Group Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Shandong Luoxin Pharmaceutical Group Famciclovir Product
Table 129. Shandong Luoxin Pharmaceutical Group Recent Developments/Updates
Table 130. Chengdu Diao Pharmaceutical Group Corporation Information
Table 131. Chengdu Diao Pharmaceutical Group Description and Business Overview
Table 132. Chengdu Diao Pharmaceutical Group Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Chengdu Diao Pharmaceutical Group Famciclovir Product
Table 134. Chengdu Diao Pharmaceutical Group Recent Developments/Updates
Table 135. HISUN Corporation Information
Table 136. HISUN Description and Business Overview
Table 137. HISUN Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. HISUN Famciclovir Product
Table 139. HISUN Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Famciclovir Distributors List
Table 143. Famciclovir Customers List
Table 144. Famciclovir Market Trends
Table 145. Famciclovir Market Drivers
Table 146. Famciclovir Market Challenges
Table 147. Famciclovir Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Famciclovir
Figure 2. Global Famciclovir Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Famciclovir Market Share by Type in 2023 & 2030
Figure 4. 125 mg Tablets Product Picture
Figure 5. 250 mg Tablets Product Picture
Figure 6. 500 mg Tablets Product Picture
Figure 7. Global Famciclovir Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Famciclovir Market Share by Application in 2023 & 2030
Figure 9. Cold Sores
Figure 10. Genital Herpes
Figure 11. Shingles
Figure 12. Global Famciclovir Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Famciclovir Market Size (2019-2030) & (US$ Million)
Figure 14. Global Famciclovir Sales (2019-2030) & (K Units)
Figure 15. Global Famciclovir Average Price (USD/Unit) & (2019-2030)
Figure 16. Famciclovir Report Years Considered
Figure 17. Famciclovir Sales Share by Manufacturers in 2023
Figure 18. Global Famciclovir Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Famciclovir Players: Market Share by Revenue in 2023
Figure 20. Famciclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Famciclovir Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Famciclovir Sales Market Share by Country (2019-2030)
Figure 23. North America Famciclovir Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Famciclovir Sales Market Share by Country (2019-2030)
Figure 27. Europe Famciclovir Revenue Market Share by Country (2019-2030)
Figure 28. Germany Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Famciclovir Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Famciclovir Revenue Market Share by Region (2019-2030)
Figure 35. China Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Famciclovir Sales Market Share by Country (2019-2030)
Figure 46. Latin America Famciclovir Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Famciclovir Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Famciclovir Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Famciclovir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Famciclovir by Type (2019-2030)
Figure 56. Global Revenue Market Share of Famciclovir by Type (2019-2030)
Figure 57. Global Famciclovir Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Famciclovir by Application (2019-2030)
Figure 59. Global Revenue Market Share of Famciclovir by Application (2019-2030)
Figure 60. Global Famciclovir Price (USD/Unit) by Application (2019-2030)
Figure 61. Famciclovir Value Chain
Figure 62. Famciclovir Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Paint Leveling Agent Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Adhesion Promoters Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Rheological Additives Market Insights, Forecast to 2030
Dec 22, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232